Everolimus Tablet
Product Images NDC 67877-720

6 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 67877-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Evero-str (Evero Str)

Evero-str (Evero Str)
Chemical structure of Everolimus, depicting its molecular arrangement with various functional groups and ring systems, corresponding to the active ingredient in the Everolimus oral tablet by Ascend Laboratories, LLC.*
FDA Label Image

Evero-fig-1 (Evero Fig 1)

Evero-fig-1 (Evero Fig 1)
A line graph illustrating estimated glomerular filtration rate (eGFR MDRD 4) over time by visit window for two treatment groups: EVR + Reduced TAC and TAC Control. The y-axis shows eGFR values (mL/min/1.73m^2) ranging from 60 to 110, and the x-axis represents various visit windows from screening (Sc) through 24 months (M24). Data points include error bars indicating variability.*
FDA Label Image

Evero-0-25mg-60tabs (Evero 0 25mg 60tabs Cart)

Evero-0-25mg-60tabs (Evero 0 25mg 60tabs Cart)
Everolimus Tablets 0.25 mg per tablet oral dosage form packaging label. The foldable carton contains 6 blister cards, each card with 10 tablets, labeled for prescription use only. Manufactured by Alkem Laboratories Ltd., India, and labeled for Ascend Laboratories, LLC. The label includes storage instructions, manufacturer details, and a barcode.*
FDA Label Image

Evero-0-5mg-60tabs-cart (Evero 0 5mg 60tabs Cart)

Evero-0-5mg-60tabs-cart (Evero 0 5mg 60tabs Cart)
Packaging label for Everolimus Tablets 0.5 mg oral tablets by Ascend Laboratories, LLC. The carton indicates a quantity of 6 blister cards with 10 tablets each. The label notes dispensing with medication guide, manufacturing by Alkem Laboratories Ltd. in India, and includes storage instructions and a barcode.*
FDA Label Image

Evero-0-75mg-60tabs-cart (Evero 0 75mg 60tabs Cart)

Evero-0-75mg-60tabs-cart (Evero 0 75mg 60tabs Cart)
Packaging label for Everolimus Tablets, 0.75 mg per tablet, by Ascend Laboratories, LLC. The label indicates the product contains 6 blister cards of 10 tablets each, for oral use. The label shows storage instructions, manufacturer details (Alkem Laboratories Ltd., India), and includes a barcode.*
FDA Label Image

Evero-1mg-60tabs-cart (Evero 1mg 60tabs Cart)

Evero-1mg-60tabs-cart (Evero 1mg 60tabs Cart)
Packaging label for Everolimus Tablets, 1 mg per tablet, manufactured by Alkem Laboratories Ltd. and labeled for Ascend Laboratories, LLC. The label shows the product name prominently, dosage strength, package contents of 6 blister cards with 10 tablets each, and storage instructions. It includes the NDC number 67877-721-31 and relevant regulatory text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.